Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
{{output}}
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 diabetes (T2D) ... ...
